{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:08:33Z","timestamp":1789740513582,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022656","name":"Centre Hospitalier Universitaire de N\u00eemes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ando.2026.102578","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:45:20Z","timestamp":1779291920000},"page":"102578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of smoking status and management of smoking cessation in moderate to severe Graves\u2019 orbitopathy. A retrospective study of 78\u00a0patients"],"prefix":"10.1016","volume":"87","author":[{"given":"Camille","family":"Collin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Perney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Jeanjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Raingeard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Julier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ando.2026.102578_bib0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2011.10.005","article-title":"Epidemiology of Grave's orbitopathy (GO) and relationship with thyroid disease","volume":"26","author":"Lazarus","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2026.102578_bib0240","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0002-9394(02)01390-9","article-title":"Late recurrence of unilateral Graves orbitopathy on the contralateral side","volume":"133","author":"Kalmann","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ando.2026.102578_bib0245","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","article-title":"Immunopathogenesis of Graves\u2019 ophthalmopathy: the role of the TSH receptor","volume":"26","author":"Iyer","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2026.102578_bib0250","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","article-title":"Clinical review 157\u00a0\u2013\u00a0Pathophysiology of Graves\u2019 ophthalmopathy: the cycle of disease","volume":"88","author":"Bahn","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20134","key":"10.1016\/j.ando.2026.102578_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/biof.5520190308","article-title":"Oxidative stress and Graves\u2019 ophthalmopathy: in vitro studies and therapeutic implications","volume":"19","author":"Bartalena","year":"2003","journal-title":"Biofactors"},{"issue":"6599","key":"10.1016\/j.ando.2026.102578_bib0260","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.295.6599.634","article-title":"Is endocrine ophthalmopathy related to smoking?","volume":"295","author":"H\u00e4gg","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"10","key":"10.1016\/j.ando.2026.102578_bib0265","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves\u2019 ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"J Endocrinol Invest"},{"issue":"8700","key":"10.1016\/j.ando.2026.102578_bib0270","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0140-6736(90)91315-2","article-title":"Association between Graves\u2019 ophthalmopathy and smoking","volume":"335","author":"Shine","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ando.2026.102578_bib0275","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1992.tb01445.x","article-title":"Graves\u2019 ophthalmopathy in relation to cigarette smoking and ethnic origin","volume":"36","author":"Tellez","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ando.2026.102578_bib0280","first-page":"8","article-title":"Graves\u2019 disease, endocrine ophthalmopathy and smoking","volume":"128","author":"Winsa","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"10.1016\/j.ando.2026.102578_bib0285","first-page":"2","article-title":"Graves\u2019 ophthalmopathy and tobacco smoking","volume":"129","author":"Tallstedt","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"10.1016\/j.ando.2026.102578_bib0290","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption","volume":"45","author":"Pfeilschifter","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ando.2026.102578_bib0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1460153","article-title":"Smoking and thyroid disorders\u00a0\u2013\u00a0a meta-analysis","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ando.2026.102578_bib0300","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF03345276","article-title":"Relationship between cigarette smoking and Graves\u2019 ophthalmopathy","volume":"27","author":"Heged\u00fcs","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"10.1016\/j.ando.2026.102578_bib0305","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.eye.6702603","article-title":"Cigarette smoking and thyroid eye disease: a systematic review","volume":"21","author":"Thornton","year":"2007","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.ando.2026.102578_bib0310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.1994.tb02445.x","article-title":"Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy","volume":"40","author":"Metcalfe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ando.2026.102578_bib0315","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002341-199907000-00007","article-title":"The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy","volume":"15","author":"Mack","year":"1999","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.ando.2026.102578_bib0320","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2249.2002.01792.x","article-title":"Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease","volume":"127","author":"Ludgate","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.ando.2026.102578_bib0325","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2026.102578_bib0330","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JOE-12-0257","article-title":"Cigarette smoke extract-induced adipogenesis in Graves\u2019 orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress","volume":"216","author":"Yoon","year":"2013","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.ando.2026.102578_bib0335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/thy.1999.9.297","article-title":"Oxygen free radicals in interleukin-1\u03b2-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves\u2019 ophthalmopathy patients","volume":"9","author":"Lu","year":"1999","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.ando.2026.102578_bib0340","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/eye.2008.310","article-title":"Oxidative stress in patients with Graves\u2019 ophthalmopathy: relationship between oxidative DNA damage and clinical evolution","volume":"23","author":"Tsai","year":"2009","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.ando.2026.102578_bib0345","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1210\/jc.2004-2275","article-title":"Overexpression of immediate early genes in active Graves\u2019 ophthalmopathy","volume":"90","author":"Lantz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ando.2026.102578_bib0350","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1089\/thy.2014.0153","article-title":"Smoking induces overexpression of immediate early genes in active Graves\u2019 ophthalmopathy","volume":"24","author":"Planck","year":"2014","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.ando.2026.102578_bib0355","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","article-title":"Cigarette smoking and treatment outcomes in Graves ophthalmopathy","volume":"129","author":"Bartalena","year":"1998","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ando.2026.102578_bib0360","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.87.6.773","article-title":"Impact of smoking on the response to treatment of thyroid-associated ophthalmopathy","volume":"87","author":"Eckstein","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ando.2026.102578_bib0365","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/bjophthalmol-2014-306463","article-title":"Smoking was associated with poor response to intravenous steroid therapy in Graves\u2019 ophthalmopathy","volume":"99","author":"Xing","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ando.2026.102578_bib0370","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17161\/kjm.vol16.18940","article-title":"Effects of smoking on outcomes of thyroid eye disease treated with teprotumumab: a retrospective cohort study","volume":"16","author":"Dell","year":"2023","journal-title":"Kans J Med"},{"issue":"6","key":"10.1016\/j.ando.2026.102578_bib0375","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-8587(21)00056-5","article-title":"Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials","volume":"9","author":"Kahaly","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ando.2026.102578_bib0380","first-page":"359","article-title":"The 2021 European Group on Graves\u2019 Orbitopathy clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"38","author":"Bartalena","year":"2022","journal-title":"Chin J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2026.102578_bib0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy guidelines for the management of Graves\u2019 orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"12","key":"10.1016\/j.ando.2026.102578_bib0390","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/thy.2022.0251","article-title":"Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ando.2026.102578_bib0395","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2026.102578_bib0400","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2018.07.038","article-title":"Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy: a randomized clinical trial","volume":"195","author":"Perez-Moreiras","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ando.2026.102578_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvaf063","article-title":"Teprotumumab improves quality of life in thyroid eye disease: meta-analysis and matching-adjusted indirect comparison","volume":"9","author":"Kahaly","year":"2025","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.ando.2026.102578_bib0410","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ando.2026.102578_bib0415","series-title":"Pr\u00e9valence nationale et r\u00e9gionale du tabagisme en France en 2021 parmi les 18\u201375 ans, d\u2019apr\u00e8s le Barom\u00e8tre de Sant\u00e9 publique France","author":"Pasquereau","year":"2022"},{"key":"10.1016\/j.ando.2026.102578_bib0420","series-title":"Pr\u00e9valence du tabagisme en France hexagonale en 2023 parmi les 18-75 ans, r\u00e9sultats de l\u2019\u00e9dition 2023 de l\u2019enqu\u00eate EROPP de l\u2019OFDT. Le point sur, novembre 2024","author":"Pasquereau","year":"2024"},{"key":"10.1016\/j.ando.2026.102578_bib0425","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Arr\u00eat de la consommation de tabac: du d\u00e9pistage individuel au maintien de l\u2019abstinence en premier recours. Recommandations de bonne pratique. 2014."},{"issue":"1","key":"10.1016\/j.ando.2026.102578_bib0430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5935\/0004-2749.20220003","article-title":"Tobacco counseling in the setting of thyroid eye disease","volume":"85","author":"Schatz","year":"2022","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"10.1016\/j.ando.2026.102578_bib0435","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1563-2571.2003.03007.x","article-title":"Advice against smoking is not effective in patients with Graves\u2019 ophthalmopathy","volume":"30","author":"Karadimas","year":"2003","journal-title":"Acta Med Austriaca"},{"issue":"7","key":"10.1016\/j.ando.2026.102578_bib0440","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.oftal.2019.03.008","article-title":"Effectiveness of oral counselling for smoke cessation in Graves orbitopathy patients","volume":"94","author":"De-Arriba-Palomero","year":"2019","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"5","key":"10.1016\/j.ando.2026.102578_bib0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/annalsmedres.2023.04.081","article-title":"Is our recommendation for smoking cessation considered in patients with Graves disease and Graves orbitopathy?","volume":"30","author":"Coskun","year":"2023","journal-title":"Ann Med Res"},{"issue":"4","key":"10.1016\/j.ando.2026.102578_bib0450","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2265.2005.02352.x","article-title":"Psychosocial morbidity of Graves\u2019 orbitopathy","volume":"63","author":"Kahaly","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ando.2026.102578_bib0455","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2265.2007.03087.x","article-title":"The impact of thyroid eye disease upon patients\u2019 wellbeing: a qualitative analysis","volume":"68","author":"Estcourt","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ando.2026.102578_bib0460","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/IOP.0000000000002318","article-title":"Evaluation of depression and anxiety in a diverse population with thyroid eye disease using the nationwide NIH All of Us database","volume":"39","author":"Lee","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:46:48Z","timestamp":1789739208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426626000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0003426626000995"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2026.102578","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of smoking status and management of smoking cessation in moderate to severe Graves\u2019 orbitopathy. A retrospective study of 78\u00a0patients","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2026.102578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102578"}}